In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies

In vivo immunotherapy of lung cancer using cross-species reactive vascular endothelial growth factor nanobodies

Objective(s): Lung cancer is the main leading cause of cancer death worldwide. Angiogenesis is the main step in proliferation and spreading of tumor cells. Targeting vascular endothelial growth factor (VEGF) is an effective approach for inhibition of cancer angiogenesis. Nanobodies (NBs) are a novel...

Full description

Bibliographic Details
Main Authors: vFatemeh Kazemi-Lomedasht v, Kamran Pooshang-Bagheri, Mahdi Habibi-Anbouhi, Ensiyeh Hajizadeh-Safar, Delavar Shahbazzadeh, Hasan Mirzahosseini, Mahdi Behdani
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2017-05-01
Series:Iranian Journal of Basic Medical Sciences
Subjects:
Angiogenesis Immunotherapy
Lung Cancer
Nanobody
Vascular endothelial growth factor
Online Access:http://ijbms.mums.ac.ir/article_8672_4f74f388df87e5b87551ed4a10f30b77.pdf

Internet

http://ijbms.mums.ac.ir/article_8672_4f74f388df87e5b87551ed4a10f30b77.pdf

Similar Items